By laksh5382 
Today American Market: The pharmaceutical sector shares fell into the Wall Street Open on Wednesday, April 9, after fear on the upcoming American tariffs, investors on pharma imports between the United States and other world countries amidst a fierce trade war between the United States and other world countries.
Stocked Fizer,
Pharma stock
Fizer Ink. The stocks are currently trading 2.56 percent less at $ 21.31 as (EDT) as compared to $ 21.84 in the previous US market. Less open with $ 21.11 in shares.
Johnson & Johnson shares are trading at $ 146.45 below 2.37 percent. 142.20, compared to about $ 150 of the previous market.
The AMGEN Stock was trading 2.48 percent less at $ 273.23 in the initial market session on the NASDAQ index, compared to $ 280.26 in the previous close. Stock open at $ 268.91 on Wall Street.
Elli Lily & Co. shares fell by more than 3 percent at $ 701.25 as compared to $ 701.25, while the previous close was $ 726.24. The stock was trading less than its initial level of $ 704.40 in the early market session of Wednesday.
Wall Street Today
9:30 am (EDT), Dow Jones Industrial Average (DJIA) open 0.68 per cent at 37,387.91 points, compared to 37,645.59 points in the previous stock market close.
Dow was trading 0.14 percent more in the initial market session on Wall Street at 37,708 points.
The S&P 500 index fell 0.35 percent at 4,965.28 points as compared to 4,965.28 points as compared to the previous stock market. The index is currently trading 0.52 percent more on Wall Street.
The Tech-Havi Nasdaq Composite Index increased by 0.18 percent to 15,295.441, compared to the previous market. The New York -based index was trading 1.5 percent more in the early market session of the marketwatch data show.
Trump pharma tariff
Donald Trump announced on Tuesday, April 8 that the United States would impose a “chief” tariff on drug imports in the Western nation amid the ongoing tariff war soon.
President Donald Trump said in his address, “We are going to tariff our pharmaceuticals … We are going to announce a major tariff on pharmaceuticals soon.”
So far, the pharmaceutical sector has been exempted from tariffs that were declared last week, but now, as the US plans to impose a duty on drug imports in the nation, investors have become cautious about pharma stock in the US.
Pharma companies worldwide depend on the supply of their raw materials from foreign countries, and American large pharmaceutical companies are no exception.
Disclaimer: The above views and recommendations are of individual analysts or broking companies, not Mint. We recommend investors to investigate with certified experts before taking any investment decisions.